⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20261556 | 1.00 | — | — | |
| SCHEMBL12288894 | 0.91 | — | — | |
| SCHEMBL29889 | 0.86 | — | — | |
| SCHEMBL11760890 | 0.86 | — | — | |
| SCHEMBL26420720 | 0.84 | — | — | |
| SCHEMBL26706040 | 0.81 | — | — | |
| SCHEMBL12921421 | 0.81 | — | — | |
| SCHEMBL26420715 | 0.81 | CHRNB2 (0.33) | — | |
| SCHEMBL26420718 | 0.81 | — | — | |
| SCHEMBL10471680 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024137865-A1 | COMPOUNDS USEFUL AS T CELL ACTIVATORS | GOSSAMER BIO SERVICES, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023161875-A1 | CYTOTOXICITY TARGETING CHIMERAS FOR PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CELLS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-08-31 | — | — | WO | disclosed |
| US-20230220162-A1 | POLYARYLENE SULFIDE PRODUCTION METHOD, POLYARYLENE SULFIDE COPOLYMER PRODUCTION METHOD, AND POLYARYLENE SULFIDE | TORAY INDUSTRIES, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230128101-A1 | FIBER-REINFORCED THERMOPLASTIC RESIN SUBSTRATE | TORAY INDUSTRIES, INC. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20220011484-A1 | OPTICAL FILTER AND IMAGING DEVICE | AGC Inc. (JP) | 2022-01-13 | — | — | US | disclosed |
| EP-3795568-A1 | FLUORINATED LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF | Pharmakea, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20210040117-A1 | CONDENSED RING COMPOUNDS HAVING DOPAMINE D3 RECEPTOR ANTAGONISTIC EFFECT | SHIONOGI & CO., LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
| EP-3127177-B1 | HIGH CAPACITY POLYMER CATHODE AND HIGH ENERGY DENSITY RECHARGEABLE CELL COMPRISING THE CATHODE | IONIC MAT INC (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10811688-B2 | Solid, ionically conducting polymer material, and methods and applications for same | IONIC MATERIALS, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| WO-2020193293-A1 | BENZOXAZINE MONOMERS AND POLYMERIC COATINGS | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) | 2020-10-01 | — | — | WO | disclosed |
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7335770-B2 | Triazine compounds and their analogs, compositions, and methods | REDDY U5 THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-7332489-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7332489-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7332490-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-7332490-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-05-31 | — | — | US | disclosed |
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-05-31 | — | — | US | disclosed |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |